| References | Journal | Year | |
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome
Lawren VandeVrede, Renaud La Joie, Elisabeth H Thijssen, Breton M Asken, Stephanie A Vento, Torie Tsuei, Suzanne L Baker, Yann Cobigo, Corrina Fonseca, Hilary W Heuer, Joel H Kramer, Peter A Ljubenkov, Gil D Rabinovici, Julio C Rojas, Howie J Rosen, Adam M Staffaroni, Brad F Boeve, Brad C Dickerson, Murray Grossman, Edward D Huey, David J Irwin, Irene Litvan, Alexander Y Pantelyat, Maria Carmela Tartaglia, Jeffrey L Dage, Adam L Boxer | JAMA Neurology | 2023 | View |
Idiopathic normal-pressure hydrocephalus: Pathophysiology and diagnosis by CSF biomarkers.
Jeppsson A, Zetterberg H, Blennow K, Wikkelso C. | Neurology | 2013 | View |
New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF.
Yang T, Hong S, O'Malley T, Sperling RA, Walsh DM, Selkoe DJ. | Alzheimers Dement | 2013 | View |
Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases.
Malekzadeh A, de Groot V, Beckerman H, van Oosten BW, Blankenstein MA, Teunissen C. | Methods. | 2012 | View |
Mass spectrometric characterization of Amyloid-β species in the 7PA2 cell model of Alzheimer's disease.
Portelius E, Olsson M, Brinkmalm G, Rüetschi U, Mattsson N, Andreasson U, Gobom J, Brinkmalm A, Hölttä M, Blennow K, Zetterberg H. | J Alzheimers Dis. | 2012 | View |
Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease.
Parker DC, Mielke MM, Yu Q, Rosenberg PB, Jain A, Lyketsos CG, Fedarko NS, Oh ES. | Int J Geriatr Psychiatry. | 2012 | View |
Abnormal peripheral chemokine profile in Huntington’s disease.
Wild, E., Magnusson, A., Lahiri, N., Krus, U., Orth, M., Tabrizi, S.J., Bjorkqvist, M. | PLoS Curr. | 2011 | View |
Long-term stability of Alzheimer's disease biomarker proteins in cerebrospinal fluid.
Schipke, C.G., Jessen, F., Teipel, S., Luckhaus, C., Wiltfang, J., Esselmann, H., Frölich, L., Maier, W., Rüther, E., Heppner, F.L., Prokop, S., Heuser, I., Peters, O. | J Alzheimers Dis. | 2011 | View |
Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis.
Steinacker, P., Fang, L., Kuhle, J., Petzold, A., Tumani, H., Ludolph, A.C., Otto, M., Brettschneider, J. | PLoS ONE | 2011 | View |
A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein.
Kuhle, J., Regeniter, A., Leppert, D., Mehling, M., Kappos, L., Lindberg, R.L., Petzold, A. | J Neuroimmunol. | 2010 | View |
Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor.
Sturm, B., Helminger, M., Steinkellner, H., Heidari, M.M., Goldenberg, H., Scheiber-Mojdehkar, B. | Eur J Clin Invest. | 2010 | View |
Comparing levels of biochemical markers in CSF from cannulated and non-cannulated rats.
Cassar, S.C., Tovcimak, A.E., Rustay, N.R., Ellis, T.A., Hooker, B.A., Witte, D.G., Li, J., Buck, W.R., Scharf, D., Muller, U., Jeromin, A., Wang, K.K., Waring, J.F. | J Neurosci Methods. | 2010 | View |
Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-ß in plasma.
Oh, E.S., Mielke, M.M., Rosenberg, P.B., Jain, A., Fedarko, N.S., Lyketsos, C.G., Mehta, P.D. | J Alzheimers Dis. | 2010 | View |
Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid.
Bjerke, M., Portelius, E., Minthon, L., Wallin, A., Anckarsater, H., Anckarsater, R., Andreasen, N., Zetterberg, H., Andreasson, U., Blennow, K. | International Journal of Alzheimer's Disease. | 2010 | View |
CSF amyloid {beta}38 as a novel diagnostic marker for dementia with Lewy bodies.
Mulugeta, E., Londos, E., Ballard, C., Alves, G., Zetterberg, H., Blennow, K., Skogseth, R., Minthon, L., Aarsland, D. | J Neurol Neurosurg Psychiatry. | 2010 | View |
CSF amyloid-{beta} and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study.
Alves, G., Bronnick, K., Aarsland, D., Blennow, K., Zetterberg, H., Ballard, C., Kurz, M.W., Andreasson, U., Tysnes, O.B., Larsen, J.P., Mulugeta, E. | J Neurol Neurosurg Psychiatry. | 2010 | View |
Exercise-induced release of cytokines in patients with major depressive disorder.
Hallberg, L., Janelidze, S., Engstrom, G., Wisen, A.G., Westrin, A., Brundin, L. | J Affect Disord. | 2010 | View |
MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS.
Fang, L., Teuchert, M., Huber-Abel, F., Schattauer, D., Hendrich, C., Dorst, J., Zettlmeissel, H., Wlaschek, M., Scharffetter-Kochanek, K., Kapfer, T., Tumani, H., Ludolph, A.C., Brettschneider, J. | J Neurol Sci. | 2010 | View |
Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.
Paris, D., Ganey, N.J., Laporte, V., Patel, N.S., Beaulieu-Abdelahad, D., Bachmeier, C., March, A., Ait-Ghezala, G., Mullan, M.J. | J Neuroinflammation. | 2010 | View |
The role of low-density receptor-related protein 1 (LRP1) as a competitive substrate of the amyloid precursor protein (APP) for BACE1.
von Einem, B., Schwanzar, D., Rehn, F., Beyer, A., Weber, P., Wagner, M., Schneckenburger, H., von Arnim, C.A.F. | Experimental Neurology | 2010 | View |
CSF amyloid- 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction.
Bibl, M., Lewczuk, P., Esselmann, H., Mollenhauer, B., Klafki, H.W., Welge, V., Wolf, S., Trenkwalder, C., Otto, M., Kornhuber, J., Wiltfang, J. | Proteomics Clinical Applications. | 2008 | View |
Peripheral elevation of IGF-1 fails to alter Ab clearance in multiple in vivo models.
Lanz, TA., Salatto, C.T., Semproni, AR., Marconi, M., Brown, TM., Richter, KE., Schmidt, K., Nelson, FR., Schachter, JB., | Biochemical Pharmacology | 2008 | View |